JP2908226B2 - Method for selecting carboxymethylcellulose sodium salt to be used as base material for cataplasm - Google Patents
Method for selecting carboxymethylcellulose sodium salt to be used as base material for cataplasmInfo
- Publication number
- JP2908226B2 JP2908226B2 JP5349107A JP34910793A JP2908226B2 JP 2908226 B2 JP2908226 B2 JP 2908226B2 JP 5349107 A JP5349107 A JP 5349107A JP 34910793 A JP34910793 A JP 34910793A JP 2908226 B2 JP2908226 B2 JP 2908226B2
- Authority
- JP
- Japan
- Prior art keywords
- viscosity
- cmc
- base
- etherification
- degree
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は展延性,保型性に優れた
パップ剤用基剤の粘着基剤に使用するカルボキシメチル
セルロースナトリウム塩(以下、CMCと略す)の選定
方法に関するものである。The present invention relates to the selection of carboxymethylcellulose sodium salt (hereinafter abbreviated as CMC) to be used as an adhesive base for a cataplasm having excellent spreadability and shape retention.
It is about the method .
【0002】[0002]
【従来の技術】パップ剤用基剤に要求される性能には、
展延性,保型性,保水性,密着性,柔軟性などが挙げら
れる。これ等の内、特に展延性,保型性は製剤時の作業
性,剤型保持性を左右するため重要となる。2. Description of the Related Art The performance required of a base for cataplasms includes:
Examples include spreadability, shape retention, water retention, adhesion, and flexibility. Of these, spreadability and shape retention are important because they affect the workability during preparation and the retention of the dosage form.
【0003】一般に、展延性と保型性とは相反する関係
にある。即ち、展延性を改善しようとすると保型性に劣
ったものになる。これは、ペーストの流動性を指標に考
えれば展延性を改善するためにはペーストの流動性を大
きくする方が良いわけであるが、一方で保型性にとって
は型流れを起こすことなど好ましくない結果に繋がった
ためである。そのため、従来より、展延性と保型性とを
付与させるには、ゼラチン系の熱可塑性を利用する技術
により対処されて来た(特開昭57−181020号公
報等)。この技術はゼラチンの熱可塑性により貼付剤製
剤時に基剤に展延性を付与し、製造された貼付剤に保型
性を保持させようとするものである。しかし、ゼラチン
ベースの基剤は気温の変化による影響を受け易く、夏期
に気温が上昇すると軟化して肌に貼付したとき不快なべ
たつきを生じたりするため問題となっていた。[0003] In general, the extensibility and the shape retention have an opposite relationship. That is, an attempt to improve the spreadability results in poor shape retention. This means that it is better to increase the fluidity of the paste in order to improve the spreadability, considering the fluidity of the paste as an index, but on the other hand, it is not preferable for mold retention to cause mold flow Because it led to the result. Therefore, conventionally, in order to impart the spreadability and the shape retaining property, a technique utilizing a gelatin-based thermoplasticity has been dealt with (for example, JP-A-57-181020). This technique is intended to impart extensibility to a base at the time of a patch preparation by the thermoplasticity of gelatin so that the prepared patch retains shape retention. However, gelatin-based bases have been problematic because they are susceptible to changes in temperature and tend to soften when the temperature rises in summer and cause unpleasant stickiness when applied to the skin.
【0004】そこで前記した問題点を解決する方法とし
て、特開昭60−60854号公報が提案されている。
即ち、重量で多価アルコール5〜40部、ポリアクリル
酸ナトリウム1〜10部、カルボキシメチルセルロース
1〜10部、アルミニウム化合物0.01〜30部、ポ
リアクリル酸エステル1〜10部、水10〜80部を含
有し、酸でpHを5ないし8に調節したものを使用する
方法を提示している。これによれば、ゼラチンの熱可塑
性によらない展延性,保型性が得られると共に、四季を
通じて安定な粘着力を有する貼付剤用基剤が得られると
いうものである。しかしこの方法は有用であったが、使
用するCMCによっては品質が安定しなかったためその
改善が切望されていた。As a method for solving the above-mentioned problems, Japanese Patent Application Laid-Open No. 60-60854 has been proposed.
That is, 5 to 40 parts by weight of polyhydric alcohol, 1 to 10 parts of sodium polyacrylate, 1 to 10 parts of carboxymethyl cellulose, 0.01 to 30 parts of an aluminum compound, 1 to 10 parts of polyacrylate, 10 to 80 parts of water by weight And a method of using a solution containing an organic acid and adjusting the pH to 5 to 8 with an acid. According to this method, spreadability and shape-retaining property not depending on the thermoplasticity of gelatin can be obtained, and a base for patches having stable adhesive strength throughout the season can be obtained. However, although this method was useful, its quality was not stable depending on the CMC used, and thus an improvement was desired.
【0005】[0005]
【発明が解決しようとする課題】本発明は、特定の粘
度,エーテル化度のCMCの中からパップ剤用基剤に優
れた展延性と保型性とを付与することができるパップ剤
用基剤に用いるCMCを選定する方法を開発することを
課題とする。The object of the invention is to solve the present invention, the specific viscosity
That can impart excellent spreadability and shape retention to the base for poultices from CMCs with different degrees of etherification and etherification
An object of the present invention is to develop a method for selecting a CMC to be used as a base material .
【0006】[0006]
【課題を解決するための手段】本発明者等は、パッブ剤
用基剤に優れた展延性と保型性とを付与するCMCに就
いて鋭意研究を重ねた結果、1%粘度が50〜500c
ps、エーテル化度が0.60〜1.00mol/C 6
のCMCを含有する含水ゲルを粘着基剤とし経皮吸収薬
剤を配合してなるパップ剤用基剤に使用するCMC上し
て、捺染業界において捺染糊の「ねばり」と「のび」と
を総合的に評価する指数であるPVI値(Printi
ng Viscosity Index:捺染粘性指
数)が特定な範囲にあるCMCを選定することにより、
展延性と保持性とを同時に付与できることを見い出し、
本発明を成すに至った。Means for Solving the Problems The present inventors have conducted intensive studies on CMC which imparts excellent spreadability and shape retention to a base for a pubic agent, and as a result, the 1% viscosity was 50 to 50%. 500c
ps, degree of etherification 0.60 to 1.00 mol / C 6
Transdermal Absorbent Using Hydrogel Containing CMC as Adhesive Base
CMC used as a base for cataplasms
In the printing industry, the PVI value (Printi) is an index for comprehensively evaluating the “stickiness” and “growth” of the printing paste.
ng Viscosity Index (print viscosity index) is selected by selecting a CMC having a specific range .
Exhibition found that the ductility and retention and the can be granted at the same time,
The present invention has been accomplished.
【0007】本発明の選定に使用されるPVT値は、B
M型粘度計(東京計器社製)でCMC溶液の25℃、3
0rpmの粘度が10000±500cpsに調製され
たCMC溶液の粘度を同粘度計で6rpmと60rpm
で測定し、次式により得られる数値である。 PVI値=60rpmの粘度/6rpmの粘度。 本発明で、1%粘度が50〜500cps、エーテル化
度が0.60〜1.00mol/C 6 のCMCの中か
ら、PVI値が0.40〜0.60のCMCを選定する
としたのは、粘度が50cps未満では保型性に劣り、
500cps超では展延性に劣るためである。また、エ
ーテル化度が0.60mol/C 6 未満では特に展延性
に劣るためであり、1.00mol/C 6 超とすると展
延性,保型性などには大きな悪影響を及ぼさないがエー
テル化剤であるモノクロル酢酸を多量に使用しなければ
ならないなどコスト的に問題が残ったためである。更
に、PVI値が0.40未満及び0.60超では粘度と
エーテル化度が前記した数値限定内にあっても展延性と
保型性とを同時に満たさないためであり、これ等の数値
の何れもが限定範囲内にあるとき本発明の目的は達成さ
れる。本発明で選定するCMCは、市販品の1%粘度が
50〜500cps,エーテル化度が0.60〜1.0
0mol/C 6 のCMCの中からPVI値が0.40〜
0.60の範囲内にあるものを適宜選定すればよい。The PVT value used in the selection of the present invention is B
Measure the CMC solution at 25 ° C with an M-type viscometer (Tokyo Keiki Co., Ltd.)
The viscosity of the CMC solution prepared to have a viscosity of 0 rpm ± 10000 ± 500 cps was measured using the same viscometer at 6 rpm and 60 rpm.
Is a numerical value obtained by the following equation. PVI value = viscosity at 60 rpm / 6 viscosity at 6 rpm. In the present invention, a CMC having a 1% viscosity of 50 to 500 cps and a degree of etherification of 0.60 to 1.00 mol / C 6
The reason for selecting a CMC having a PVI value of 0.40 to 0.60 was that the viscosity was less than 50 cps and the shape retention was poor,
If it exceeds 500 cps, the extensibility is inferior. If the degree of etherification is less than 0.60 mol / C 6 , the spreadability is particularly poor. If the degree of etherification exceeds 1.00 mol / C 6 , there is no significant adverse effect on the spreadability , shape retention, etc. This is because there remains a problem in terms of cost such as the necessity of using a large amount of monochloroacetic acid as an agent. Further, when the PVI value is less than 0.40 and more than 0.60, even if the viscosity and the degree of etherification are within the above-mentioned numerical limits, the spreadability and the shape retention are not satisfied at the same time. The object of the present invention is achieved when both are within the limited range. The CMC selected in the present invention has a 1% viscosity of a commercial product.
50-500 cps, degree of etherification 0.60-1.0
The PVI value of the CMC of 0 mol / C 6 is 0.40 to 0.40.
What is in the range of 0.60 may be appropriately selected .
【0008】本発明により選定したCMCを使用するパ
ップ剤用基剤の成分としては、1%粘度,エーテル化度
及びPVI値が前記範囲内にあるCMCの他に、例えば
ポリアクリル酸ナトリウム,グリセリン,ソルビトー
ル,プロピレングリコール,エチレングリコールなどの
多価アルコール,アラビアゴムなどの粘着剤、カオリ
ン,酸化チタンなどの白色無機顔料などが挙げられる。
更に前記のパップ剤用基剤に配合してパップ剤を製剤す
るための経皮吸収薬剤としては、サリチル酸メチル,サ
リチル酸グリコール,ジフェンヒドラミン類,インドメ
タシン,フルルビプロフェン,ケトンプロフェン及びカ
ンフル,メントールなどの精油成分などの単独或いはそ
れ等の混合物が挙げられる。[0008] as a component of Pas <br/>-up agents for bases to use CMC in more selected in the present invention, 1% viscosity, in addition to etherification degree and PVI value of CMC within the range, Examples thereof include polyhydric alcohols such as sodium polyacrylate, glycerin, sorbitol, propylene glycol and ethylene glycol, adhesives such as gum arabic, and white inorganic pigments such as kaolin and titanium oxide.
Further, as a transdermal absorption agent for preparing a poultice by mixing with the above-mentioned poultice base, methyl salicylate, glycol salicylate, diphenhydramines, indomethacin, flurbiprofen, ketoneprofen and camphor, menthol, etc. Of the essential oil component alone or a mixture thereof.
【0009】[0009]
【実施例】以下に本発明に就いて詳述するが、本発明は
これ等によって限定されるものではない。EXAMPLES The present invention will be described in detail below, but the present invention is not limited by these.
【0010】実施例1 1%粘度が168cps、エーテル化度が0.81mo
l/C 6、PVI値が0.46のCMCを選定して、表
1に示した配合成分及び割合のものを、CMC、ポリア
クリル酸ナトリウム、カオリンの順で乳鉢に入れ粉体混
合する。次いでグリセリンを添加し良く混和させる。更
に水を徐々に添加しながら良く練合してパップ剤用基剤
ペーストを得た。Example 1 1% viscosity: 168 cps, degree of etherification: 0.81 mol
1 / C 6 , a CMC having a PVI value of 0.46 is selected, and the components and proportions shown in Table 1 are placed in a mortar in the order of CMC, sodium polyacrylate, and kaolin, and powder-mixed. Then, glycerin is added and mixed well. The mixture was kneaded well while gradually adding water to obtain a base paste for a poultice.
【0011】実施例2 1%粘度が300cps、エーテル化度が0.88mo
l/C 6、PVI値が0.53のCMCを選定して、表
1に示した配合成分及び割合のものを、実施例1と全く
同様の手順で調製してパップ剤用基剤ペーストを得た。Example 2 1% viscosity: 300 cps, degree of etherification: 0.88 mol
1 / C 6 , a CMC having a PVI value of 0.53 was selected, and the components and ratios shown in Table 1 were prepared in exactly the same procedure as in Example 1 to prepare a base paste for a poultice. Obtained.
【0012】比較例1 1%粘度が800cps、エーテル化度が0.65mo
l/C 6、PVI値が0.42のCMCを使用して、表
1に示した配合成分及び割合のものを、実施例1と全く
同様の手順で調製してパップ剤用基剤ペーストを得た。Comparative Example 1 1% viscosity: 800 cps, degree of etherification: 0.65 mol
Using CMC having a l / C 6 and a PVI value of 0.42, the components and ratios shown in Table 1 were prepared in exactly the same procedure as in Example 1 to prepare a base paste for a poultice. Obtained.
【0013】比較例2 1%粘度が30cps、エーテル化度が0.85mol
/C 6、PVI値が0.56のCMCを使用して、表1
に示した配合成分及び割合のものを、実施例1と全く同
様の手順で調製してパップ剤用基剤ペーストを得た。Comparative Example 2 1% viscosity: 30 cps, degree of etherification: 0.85 mol
/ C 6 , using a CMC with a PVI value of 0.56, Table 1
Were prepared in exactly the same procedure as in Example 1 to obtain a cataplasm base paste.
【0014】比較例3 1%粘度が190cps、エーテル化度が1.39mo
l/C 6、PVI値が0.59のCMCを使用して、表
1に示した配合成分及び割合のものを、実施例1と全く
同様の手順で調製してパップ剤用基剤ペーストを得た。Comparative Example 3 1% viscosity: 190 cps, degree of etherification: 1.39 mol
Using CMC having a l / C 6 and a PVI value of 0.59, the components and ratios shown in Table 1 were prepared in exactly the same manner as in Example 1 to prepare a base paste for a poultice. Obtained.
【0015】比較例4 1%粘度が324cps、エーテル化度が0.40mo
l/C 6、PVI値が0.45のCMCを使用して、表
1に示した配合成分及び割合のものを、実施例1と全く
同様の手順で調製してパップ剤用基剤ペーストを得た。Comparative Example 4 1% viscosity: 324 cps, degree of etherification: 0.40 mo
1 / C 6 , using a CMC having a PVI value of 0.45, the components and proportions shown in Table 1 were prepared in exactly the same procedure as in Example 1 to prepare a base paste for a poultice. Obtained.
【0016】比較例5 1%粘度が215cps、エーテル化度が0.70mo
l/C 6、PVI値が0.67のCMCを使用して、表
1に示した配合成分及び割合のものを、実施例1と全く
同様の手順で調製してパップ剤用基剤ペーストを得た。Comparative Example 5 1% viscosity: 215 cps, degree of etherification: 0.70 mol
Using CMC having a l / C 6 and a PVI value of 0.67, the components and the proportions shown in Table 1 were prepared in exactly the same procedure as in Example 1 to prepare a base paste for a poultice. Obtained.
【0017】比較例6 1%粘度が375cps、エーテル化度が0.68mo
l/C 6、PVI値が0.32のCMCを使用して、表
1に示した配合成分及び割合のものを、実施例1と全く
同様の手順で調製してパップ剤用基剤ペーストを得た。Comparative Example 6 1% viscosity: 375 cps, degree of etherification: 0.68 mol
1 / C 6 , using a CMC having a PVI value of 0.32, the components and proportions shown in Table 1 were prepared in exactly the same procedure as in Example 1 to prepare a base paste for a poultice. Obtained.
【0018】以上の実施例1,2及び比較例1〜6から
得られたペーストの性能を表2に示した。表2に示され
るように、以下のCMCを選定することにより展延性と
保型性とを同時に満たすパップ剤用基剤が得られること
が実証された。 (1)1%粘度 50〜500cps (2)エーテル化度 0.60〜1.00mol
/C 6 (3)PVI値 0.40〜0.60From the above Examples 1 and 2 and Comparative Examples 1 to 6
Table 2 shows the performance of the obtained paste. Shown in Table 2
So, the following CMCBy selectingExtensibility and
A base for cataplasms that simultaneously satisfies mold retention
Has been demonstrated. (1) 1% viscosity 50 to 500 cps (2) Degree of etherification 0.60 to 1.00 mol
/C 6 (3) PVI value 0.40 to 0.60
【0019】[0019]
【表1】 [Table 1]
【0020】[0020]
【表2】 [Table 2]
【0021】 保型性:ペーストを先端径が8mmのチューブに入れ、
ガラス板上にストランド状に押し出し、25℃中で24
時間放置してストランドの状態を直後のそれと比較評価
した。 ◎:全くダレない ○:殆んどダレない △:ややダレる ×:著しくダレる 展延性:ペーストをステージに一定量載せてガラス棒で
引き延ばし、展延した面積を計測しcm2/gで表わし
た。尚、ステージとガラス棒とのギャップは0.5mm
とした。Retainability: Put the paste in a tube having a tip diameter of 8 mm,
Extruded in a strand on a glass plate.
After standing for a time, the state of the strand was evaluated in comparison with that immediately after. :: No dripping at all ○: Almost no dripping Δ: Slight dripping ×: Marked dripping Extensibility: A fixed amount of paste was placed on a stage and stretched with a glass rod, and the spread area was measured and measured in cm 2 / g. Expressed. The gap between the stage and the glass rod is 0.5 mm
And
【0022】[0022]
【発明の効果】以上に詳述した如く、表1に示したよう
な1%粘度とエーテル化度とPVI値とが特定な範囲内
に在るCMCを選定して使用すると、パップ剤用基剤と
した場合に展延性と保型性とに優れるペーストが得られ
ることが判明し、本発明を完成した。As described in detail above , when a CMC having a 1% viscosity, a degree of etherification and a PVI value within a specific range as shown in Table 1 is selected and used, a base for a poultice is obtained. It has been found that a paste having excellent spreadability and shape retention can be obtained when used as an agent, and the present invention has been completed.
フロントページの続き (56)参考文献 特開 昭62−138538(JP,A) 特開 昭59−110647(JP,A) 特開 昭59−53411(JP,A) 特開 昭59−108045(JP,A) 特開 昭63−93717(JP,A) (58)調査した分野(Int.Cl.6,DB名) A61K 9/70 Continuation of the front page (56) References JP-A-62-138538 (JP, A) JP-A-59-110647 (JP, A) JP-A-59-53411 (JP, A) JP-A-59-108045 (JP, A) , A) JP-A-63-93717 (JP, A) (58) Fields investigated (Int. Cl. 6 , DB name) A61K 9/70
Claims (1)
ル化度が0.60〜1.00mol/C 6 のカルボキシ
メチルセルロースナトリウム塩を含有する含水ゲルを粘
着基剤とし経皮吸収薬剤を配合してなるパップ剤用基剤
に使用するカルボキシメチルセルロースナトリウム塩と
して、PVI値が0.40〜0.60のものを選定する
ことを特徴とするパップ剤用基剤に用いるカルボキシメ
チルセルロース塩の選定方法。 1. A 1% viscosity of 50 to 500 cps,
Viscosity hydrogel that Le degree is carboxymethyl cellulose sodium salt 0.60~1.00mol / C 6
Base for cataplasm containing transdermal drug as base material
Carboxymethylcellulose sodium salt used for
Carboxymethyl that to, PVI value used in a base for poultices, characterized in <br/> be selected ones of 0.40 to 0.60
How to select chill cellulose salts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5349107A JP2908226B2 (en) | 1993-12-28 | 1993-12-28 | Method for selecting carboxymethylcellulose sodium salt to be used as base material for cataplasm |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5349107A JP2908226B2 (en) | 1993-12-28 | 1993-12-28 | Method for selecting carboxymethylcellulose sodium salt to be used as base material for cataplasm |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07196481A JPH07196481A (en) | 1995-08-01 |
| JP2908226B2 true JP2908226B2 (en) | 1999-06-21 |
Family
ID=18401541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5349107A Expired - Fee Related JP2908226B2 (en) | 1993-12-28 | 1993-12-28 | Method for selecting carboxymethylcellulose sodium salt to be used as base material for cataplasm |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2908226B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7066489B2 (en) * | 2018-04-06 | 2022-05-13 | 第一工業製薬株式会社 | Manufacturing method of microcapsules |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5953411A (en) * | 1982-09-20 | 1984-03-28 | Nippon Kayaku Co Ltd | Base for poultice |
| JPS59108045A (en) * | 1982-12-11 | 1984-06-22 | Daicel Chem Ind Ltd | Carboxymethylcellulose gel composition and its production |
| JPS59110617A (en) * | 1982-12-17 | 1984-06-26 | Lion Corp | Gelatin-free poultice |
| JPS62138538A (en) * | 1985-12-13 | 1987-06-22 | Daicel Chem Ind Ltd | Hydrous gel composition |
| JPS6393717A (en) * | 1986-10-09 | 1988-04-25 | Sekisui Chem Co Ltd | Sticking agent or adhesive agent for oral mucosa |
-
1993
- 1993-12-28 JP JP5349107A patent/JP2908226B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07196481A (en) | 1995-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0522685B2 (en) | ||
| JP2003530455A (en) | Pressure sensitive adhesive composition | |
| JP2908226B2 (en) | Method for selecting carboxymethylcellulose sodium salt to be used as base material for cataplasm | |
| JPS63201119A (en) | Plaster composition | |
| JPH06287133A (en) | Non-aqueous pasty composition for oral cavity application | |
| JPH0662401B2 (en) | Ketoprofen-containing patch | |
| JPH08319213A (en) | Adhesive pack sheet for beauty and medicine | |
| TWI451884B (en) | Butenafine hydrochloride containing hydrophilic patch | |
| JPH062150B2 (en) | Base for patches | |
| EP2620136B1 (en) | Denture adhesive hydrogel with dry tack | |
| JP2007186510A (en) | Denture stabilizer composition | |
| JPS6034924B2 (en) | Poultice and its manufacturing method | |
| PT97174A (en) | Process for the preparation of an adhesive composition comprising a polymeric organic adhesive and a polymer substituted with amine | |
| US20090142389A1 (en) | Hydrogel sheet and production method thereof | |
| JPH0532521A (en) | Gel-like cosmetic | |
| WO1997031614A1 (en) | Denture stabilizer composition | |
| JPH07223938A (en) | Bath for patch | |
| JP2807320B2 (en) | paste | |
| JP3382032B2 (en) | Indomethacin patch | |
| JP3002733B2 (en) | Indomethacin-containing patch | |
| JP4969081B2 (en) | Denture stabilizer | |
| JP2009161618A (en) | Additive for adhesive patch composition, adhesive patch composition containing the same, and method for producing the composition | |
| JPS61244369A (en) | Water absorbable pressure-sensitive adhesive composition | |
| JPS63309572A (en) | Medical self-adhesive composition and its production | |
| JPS6116369B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080402 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090402 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090402 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100402 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100402 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110402 Year of fee payment: 12 |
|
| LAPS | Cancellation because of no payment of annual fees |